But it noted it did not establish a causal relationship
3, 2023, Constantine GD, Archer DF, Graham S, Bernick BA, Mirkin S
Key findings include: IV TXA significantly reduces hematoma risk (OR = 0.37, P = .008) Topical TXA significantly lowers infection risk (OR = 0.41, P = .005) No significant impact was observed for seroma or general wound-healing complications These results highlight how systemic and topical TXA can be leveraged to enhance patient safety and optimize surgical outcomes
This alignment between medication peak and challenging eating moments improves both weight loss and eating satisfaction
JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes
Track your results and adjust based on personal experience